Infante, M.; Arranz-Ledo, M.; Lastra, E.; Abella, L.E.; Ferreira, R.; Orozco, M.; Hernández, L.; MartÃnez, N.; Durán, M.
Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing? Int. J. Mol. Sci. 2022, 23, 11499.
https://doi.org/10.3390/ijms231911499
AMA Style
Infante M, Arranz-Ledo M, Lastra E, Abella LE, Ferreira R, Orozco M, Hernández L, MartÃnez N, Durán M.
Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing? International Journal of Molecular Sciences. 2022; 23(19):11499.
https://doi.org/10.3390/ijms231911499
Chicago/Turabian Style
Infante, Mar, Mónica Arranz-Ledo, Enrique Lastra, Luis Enrique Abella, Raquel Ferreira, Marta Orozco, Lara Hernández, Noemà MartÃnez, and Mercedes Durán.
2022. "Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?" International Journal of Molecular Sciences 23, no. 19: 11499.
https://doi.org/10.3390/ijms231911499
APA Style
Infante, M., Arranz-Ledo, M., Lastra, E., Abella, L. E., Ferreira, R., Orozco, M., Hernández, L., MartÃnez, N., & Durán, M.
(2022). Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing? International Journal of Molecular Sciences, 23(19), 11499.
https://doi.org/10.3390/ijms231911499